| Pharmaceutical Information |
| Drug Name |
Estazolam |
| Drug ID |
BADD_D00819 |
| Description |
A benzodiazepine with anticonvulsant, hypnotic, and muscle relaxant properties. It has been shown in some cases to be more potent than diazepam or nitrazepam. |
| Indications and Usage |
For the short-term management of insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings. |
| Marketing Status |
approved; illicit |
| ATC Code |
N05CD04 |
| DrugBank ID |
DB01215
|
| KEGG ID |
D00311
|
| MeSH ID |
D004949
|
| PubChem ID |
3261
|
| TTD Drug ID |
D0P2CK
|
| NDC Product Code |
48087-0031; 0591-0744; 58159-096; 12828-0077; 70954-481; 70954-480; 0591-0745; 51862-074; 51862-073 |
| UNII |
36S3EQV54C
|
| Synonyms |
Estazolam | Tasedan | ProSom | D-40TA | D40TA | Nuctalon |
|
| Chemical Information |
| Molecular Formula |
C16H11ClN4 |
| CAS Registry Number |
29975-16-4 |
| SMILES |
C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4 |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
